July 24, 2017 8:05 AM ET


Company Overview of Aspireo Pharmaceuticals Ltd.

Company Overview

Aspireo Pharmaceuticals Ltd. develops compounds for the treatment of acromegaly and certain hormone active tumor types resulting from hypophyse disorders. It offers Somatoprim (DG3173), a novel somatostatin analogue that regulates endocrine system and affects neurotransmission and cell proliferation via interaction with G-protein-coupled somatostatin receptors and inhibition of the release of various secondary hormones. The company provides Somatoprim to treat patients with the various indications, including acromegaly, carcinoid tumors, GEP-NET, diabetic retinopathy, and cushings diseases. Aspireo Pharmaceuticals Ltd. is based in Tel Aviv, Israel.

Tel Aviv,  


Key Executives for Aspireo Pharmaceuticals Ltd.

Chief Executive Officer
Chief Financial Officer
Age: 67
Chief Business Officer
Compensation as of Fiscal Year 2017.

Similar Private Companies By Industry

Company Name Region
3PLW Ltd. Middle East/Africa
Accelerated Evolution Biotechnologies Ltd Middle East/Africa
Adante Ltd. Middle East/Africa
Advanced Biotechnology Ltd. Middle East/Africa
Advanced Medical Analysis (AMA) Ltd. Middle East/Africa

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
The Advertising Council, Inc. United States
Bertelsmann AG Europe
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Aspireo Pharmaceuticals Ltd., please visit www.aspireopharma.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.